Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

By HospiMedica International staff writers
Posted on 18 Nov 2026

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. More...

However, artificial intelligence (AI) systems may still generate recommendations despite insufficient evidence, raising concerns about their reliability in high-stakes clinical decisions. To improve decision-making, researchers have developed a causal AI approach that can withhold treatment recommendations when the available evidence is inconclusive.

Researchers at Constructor University are investigating how causal artificial intelligence (AI) and large language models (LLMs) can support decision-making in cancer treatment. Their approach combines causal machine learning, uncertainty assessment, and AI-generated explanations to distinguish between predicting treatment outcomes and determining whether the available evidence is sufficiently reliable to guide individual clinical decisions.

The study used real-world ovarian cancer patient data with simulated treatment assignments and outcomes to evaluate the system’s ability to generate reliable recommendations. Rather than providing a treatment direction when evidence was insufficient, the model was designed to abstain from making a recommendation. At the selected confidence threshold, it withheld recommendations in 99.4% of cases, demonstrating that improved predictive performance alone does not necessarily translate into reliable individualized treatment guidance.

The work builds on earlier causal AI research in supply-chain decision-making conducted with BMW Group and published in Supply Chain Analytics. That prior project used causal models and large language models to examine possible cause-and-effect pathways in supplier risk, including delivery delays, backlogs, and escalation levels. The cancer-focused research, titled “When Individualized Causal Predictions Are Not Actionable: Failure Analysis, Abstention and a Runtime-Checked Narrative Agent on Ovarian-Cancer Covariates,” will be presented at NeurIPS 2026 on Dec. 11 in Sydney, Australia.

“If we can use causal AI to understand complex industrial systems and make better decisions, why couldn't we explore similar ideas in medicine, where the consequences of those decisions are far more significant?” said Ishansh Gupta, Constructor University Lecturer and Postdoctoral Researcher.

“Our cancer research is still at an early stage. The next steps would involve working closely with medical researchers and clinicians, validating the models against appropriate clinical data and, eventually, investigating prospective clinical evaluations and trials, where justified and approved. The ambition is not to replace doctors with AI, but to develop tools that could eventually help them understand complex treatment decisions with greater confidence,” added Gupta.

Related Links
Constructor University


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Adhesive
MED 5570U
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.